Koning Corporation

Koning Corporation manufactures breast imaging systems, specifically the Koning Vera Breast CT (KBCT), a cone-beam computed tomography device designed for advanced 3D breast tissue visualization. The Koning Vera delivers high-resolution images without compression in less than 10 seconds per breast, with radiation dose levels comparable to diagnostic mammography. The system is multifunctional, capable of diagnostic workups, 3D-guided biopsy, post-operative monitoring, neoadjuvant monitoring, dense breast evaluation, implant assessment, and contrast-enhanced imaging. Koning has over 20 years of development history in cone-beam CT technology and holds more than 120 patents globally. The company won the 2016 Frost and Sullivan New Innovation Award in Breast Imaging. The Koning Vera addresses limitations of standard mammography, which misses approximately 30% of breast cancers and up to 70% in women with dense breast tissue. The device detects lesions as small as 2mm and calcifications as small as 200 microns, supporting early-stage cancer detection (stage 0-1) where five-year survival rates reach 99%. The technology is available at multiple locations worldwide, and the company offers provider partnerships to expand access. Clinical applications include diagnostic evaluation, surgical planning, biopsy guidance, and post-treatment monitoring in breast imaging centers and hospitals.